Suchergebnisse - "Vestbo, Jørgen"

PubPharm (47)

1

Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD : a contemporary population-based cohort

enthalten in: Thorax | 2020

von Çolak, Y. | Nordestgaard, B. | Vestbo, J. | +2

2

Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD

enthalten in: The European respiratory journal | 2020

von Mathioudakis, A. | Bikov, A. | Foden, P. | +4

3

Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study

enthalten in: American journal of respiratory and critical care medicine | 2020

von Çolak, Y. | Afzal, S. | Nordestgaard, B. | +2

CommentIn: Am J Respir Crit Care Med. 2020 Mar 15;201(6):641-642. - PMID 31899658

4

Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk

enthalten in: International journal of chronic obstructive pulmonary disease | 2020

von Langholm, L. | Rønnow, S. | Sand, J. | +6

5

Type IV collagen turnover is predictive of mortality in COPD : a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort

enthalten in: Respiratory research | 2019

von Rønnow, S. | Sand, J. | Langholm, L. | +6

6

Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups

enthalten in: Respiratory medicine | 2019

von Bakerly, N. | Woodcock, A. | Collier, S. | +6

7

Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study

enthalten in: Respiratory medicine | 2018

von Svedsater, H. | Jones, R. | Bosanquet, N. | +6

8

At the Root : Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

enthalten in: American journal of respiratory and critical care medicine | 2018

von Martinez, F. | Han, M. | Allinson, J. | +23

CommentIn: Am J Respir Crit Care Med. 2018 Aug 1;198(3):411-412. - PMID 29653066

9

β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT

enthalten in: Annals of the American Thoracic Society | 2018

von Dransfield, M. | McAllister, D. | Anderson, J. | +11

CommentIn: Ann Am Thorac Soc. 2018 May;15(5):558-559. - PMID 29714105

10

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE) : a double-blind, parallel group, randomised controlled trial

enthalten in: Lancet (London, England) | 2018

von Papi, A. | Vestbo, J. | Fabbri, L. | +10

CommentIn: Lancet. 2018 Mar 17;391(10125):1003-1004. - PMID 29395271

1
2
3
4
5
Nächster »
[5]